Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity.

OBJECTIVE A significant percentage of nonautoimmune forms of diabetes presents among children in all age groups, with a remarkable increase with age. DESIGN From October 1992 to October 2004, a total of 859 children less than 18 yr of age were newly diagnosed with diabetes at the Barbara Davis Center for Childhood Diabetes and had blood samples obtained within 2 wk of disease onset for analysis of antiislet autoantibodies to glutamic acid decarboxylase-65, insulinoma-associated antigen-2, insulin, and islet cell autoantibodies. The relationship of autoantibody positivity with human leukocyte antigen (HLA) class II, body mass index (BMI), glycosylated hemoglobin, age, and ethnicity was analyzed. RESULTS Overall 19% (159 of 859) of these children with newly diagnosed diabetes were negative for all autoantibodies, and autoantibody negativity was significantly increased with age (P < 0.01). The Hispanic and Black subjects had significantly increased autoantibody negativity among older children with higher BMI than White subjects. The patients with the highest risk HLA genotype, DR3-DQ2/DR4-DQ8, were significantly less autoantibody negative (P = 0.001), whereas the HLA-protective allele, DQB1*0602, was significantly increased among the autoantibody-negative patients (P < 0.0001). Insulin autoantibodies were dramatically age dependent and were inversely correlated with age in both prevalence (P < 0.0001) and levels (P < 0.0001). Autoantibody positivity was inversely correlated with both BMI and age using multivariate analysis (P < 0.0001 and P = 0.0078, respectively). CONCLUSIONS A significant percentage of children newly diagnosed with diabetes are negative for all antiislet autoantibodies with a marked increase in obesity-associated autoantibody-negative diabetes after age 10, suggesting diabetes heterogeneity at all ages.

[1]  W. Tamborlane,et al.  Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents , 2006, Diabetologia.

[2]  E. Bonifacio,et al.  Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. , 2004, The Journal of clinical investigation.

[3]  T. Waldhör,et al.  Type 2 diabetes mellitus is rare but not absent in children under 15 years of age in Austria , 2003, European Journal of Pediatrics.

[4]  S. Arslanian Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[5]  M. Rewers,et al.  Identification of Children with Early Onset and High Incidence of Anti-islet Autoantibodies , 2002 .

[6]  M A Waclawiw,et al.  Racial divergence in adiposity during adolescence: The NHLBI Growth and Health Study. , 2001, Pediatrics.

[7]  Michael M. Engelgau,et al.  Type 2 diabetes among North adolescents: An epidemiologic health perspective , 2000 .

[8]  M. Rewers,et al.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Jones,et al.  Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. , 1999, Endocrinology and metabolism clinics of North America.

[10]  I. Mackay,et al.  Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43) , 1999, Diabetologia.

[11]  N. Breslow,et al.  Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset: Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset , 1999 .

[12]  H. Chase,et al.  Dual-parameter model for prediction of type I diabetes mellitus. , 1998, Proceedings of the Association of American Physicians.

[13]  P. Bingley,et al.  Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers , 1997, Diabetes.

[14]  R. Bretzel,et al.  Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status. , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  W. Scherbaum,et al.  Distinct Genetic and Immunological Features in Patients With Onset of IDDM Before and After Age 40 , 1997, Diabetes Care.

[16]  M. Rewers,et al.  Antiislet autoantibodies usually develop sequentially rather than simultaneously. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  M. Rewers,et al.  Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY) , 1996, Diabetologia.

[18]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[19]  Å. Lernmark,et al.  Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. , 1995, The Journal of clinical investigation.

[20]  J. Krischer,et al.  Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. , 1994, The Journal of clinical investigation.

[21]  C. Boitard,et al.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[22]  J. Krischer,et al.  High frequency of abnormal glucose tolerance in DQA1*0102/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial—Type 1 Diabetes , 2004, Diabetologia.

[23]  J. Krischer,et al.  Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.

[24]  R. Buzzetti,et al.  Autoantibody negative new onset Type 1 diabetic patients lacking high risk HLA alleles in a Caucasian population: are these Type 1b diabetes cases? , 2000, Diabetes/metabolism research and reviews.

[25]  N. Breslow,et al.  Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.